Emergent BioSolutions secures $60M contracts
Source: SeekingAlpha
2026-03-25 16:21:01 ET
More on Emergent Biosolutions
- Emergent BioSolutions Earnings: Revenue, Margins, And GAAP Losses Paint A Mixed Picture
- Emergent BioSolutions plummets on weak 2026 revenue guidance, Q4 results
- Emergent BioSolutions outlines $720M–$760M 2026 revenue target as transformation plan advances
Read the full article on Seeking Alpha
For further details see:
Emergent BioSolutions secures $60M contracts
Harte Hanks Inc.
NASDAQ: HHS
HHS Trading
7.08% G/L:
$2.485 Last:
3,592 Volume:
$2.32 Open:
HHS Latest News
$21,577,051
5,405,385
0.75%
12
N/A
Industrial Conglomerates
Industrials
US
Chelmsford
